Sun Pharma Advanced Research Co Ltd
BSE:532872
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sun Pharma Advanced Research Co Ltd
BSE:532872
|
IN |
|
Innocan Pharma Corp
OTC:INNPF
|
IL |
|
C
|
Centrica PLC
OTC:CPYYY
|
UK |
|
W
|
Webjet Ltd
OTC:WEBJF
|
AU |
|
E
|
ExpreS2ion Biotech Holding AB
F:5JD
|
SE |
|
C
|
Corpfin Capital Prime Retail II Socimi SA
MAD:YPR2
|
ES |
|
P
|
Procore Technologies Inc
F:5PT
|
US |
|
B
|
Bristow Group Inc
F:ERG1
|
US |
|
J&T Global Express Ltd
F:J92
|
CN |
|
Amplify Energy Corp
F:2OQ
|
US |
|
R
|
Resverlogix Corp
XMUN:RFS
|
CA |
|
B
|
Builders FirstSource Inc
SWB:B1F
|
US |
|
AFC Ajax NV
AEX:AJAX
|
NL |
|
A
|
AFC Ajax NV
XMUN:AJXA
|
NL |
|
C
|
Central Plaza Hotel PCL
SET:CENTEL
|
TH |
|
F
|
Fraport Frankfurt Airport Services Worldwide AG
DUS:FRA
|
DE |
|
Minerva SA
BOVESPA:BEEF3
|
BR |
|
TPG Telecom Ltd
ASX:TPG
|
AU |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SPARC's stock price target?
Not Available
SPARC does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Sun Pharma Advanced Research Co Ltd?
Projected CAGR
528%
Over the last 14 years, the compound annual growth rate for Revenue has been 35%. The projected CAGR for the next 2 years is 528%.
What is the Operating Income forecast for Sun Pharma Advanced Research Co Ltd?
Projected CAGR
913%
The compound annual growth rate for Operating Income over the next 1 year is 913%.
What is the Pre-Tax Income forecast for Sun Pharma Advanced Research Co Ltd?
Projected CAGR
25%
The compound annual growth rate for Pre-Tax Income over the next 6 years is 25%.
What is the Net Income forecast for Sun Pharma Advanced Research Co Ltd?
Projected CAGR
19%
The compound annual growth rate for Net Income over the next 6 years is 19%.
